Health insurers have to get personal: Less than half of consumers are fully satisfied with their health plan provider, but age and experience have a lot to do with their views.
Digital health startups to watch: We spotlight virtual behavioral health provider Better Life Partners and school-based telemental health company Daybreak Health on the back of fresh funding.
Blue Shield of California drops Caremark for piecemeal PBM model: We examine if the insurer’s decision could start a trend and take some power away from dominant pharmacy benefit managers.
Medicaid disenrollment hurts consumers, providers: More than one-third of Medicaid members say their health plan hasn’t contacted them about renewing their coverage. Consumer spending will take a hit.
On today's episode, we discuss Gen Zers and healthcare: what the beginning of their journey looks like, social media as an entry point, and what they want from their experience. "In Other News," we talk about Amazon expanding its Amazon Clinic telehealth services to include video visits and how connected fitness is getting on post-pandemic. Tune in to the discussion with our analysts Rajiv Leventhal and Lisa Phillips.
YouTube updates its medical misinformation guidelines: It’s taking more steps to remove inaccurate health content. Other social media platforms should take notice.
Amazon Pharmacy dispenses discounts on insulin: It’s automatically applying drug manufacturers’ coupons to lower costs in another bid to gain attention in online pharmacy.
Docs, pharmacists want better teamwork: Pharmacists stepped up to provide certain medical services during the pandemic. Now, they may become a permanent fixture in the care funnel.
Femtech companies grow despite the digital health downturn: Women’s health startups are garnering investor attention in a post-Roe America. We explore how they can build on the momentum and reach more female patients.
Cigna partners with Virgin Pulse: Cigna members will get a personalized health and wellness platform to record their health journeys. But without real incentives, we’re skeptical it’ll see long-term engagement.
Big Pharma’s drug prices in the crosshairs: A new report from AARP shows the list prices for the top 25 Medicare Part D drugs grew ~226% since they were launched. It’s down to the wire in the feud over Medicare prescription drug price negotiations.
We’re seeing record bankruptcies among VC-backed startups. Factors include rate hikes, investment shortages, and bank collapses. AI funding rises, but potential oversaturation looms.
Generative AI isn’t a strategy by itself: But healthcare execs should start nailing down their AI priorities soon, before the next wave of AI tools breaks over their heads.
Digital health startups to watch: We spotlight kidney health management company Healthmap and at-home medical exam platform TytoCare on the back of fresh funding.
Healthcare, pharma digital ad spending slowdown impacts Doximity: The company recognizes that its digital marketing solutions strategy must shift to meet its customers’ needs.
Remote monitoring for heart failure patients: Geisinger and Bodyport are expanding a program to non-invasively measure fluid levels and other biometrics on a daily basis. It’s an advance on conventional weight scales.
Patients are digital health believers: Healthcare providers are actively responding to consumer demands for better technology. They’ll need to keep it going, or risk losing patients to competitors.
Employers are worried about covering GLP-1s for weight loss: Prescriptions written for obesity drugs are skyrocketing. We examine Teladoc’s plan to rein in the costs for employers.
Connected fitness users are pulling the plug: Our updated forecast shows US adults are heading back to the gym or outdoor fitness routines, leaving Peloton, Mirror, and others behind.
The Mark Cuban Cost Plus Drug juggernaut keeps rolling: Now that it’s turned to the self-insured employer market, the low-cost drug company is making deals to expand its operations and offerings. Here’s the latest.